Novel transcript, antisense to HSPH1 (ENSG00000295391)

The target "novel transcript, antisense to HSPH1" (ENSG00000295391) refers to a predicted non-coding RNA transcribed from the antisense strand of the HSPH1 gene, a molecular chaperone that participates in stress response and cancer biology[2]. As an annotated transcript, it lacks protein-coding capability, and its biological role remains uncharacterized; it is not recognized as a classical therapeutic target such as a receptor, enzyme, or transporter. There is no evidence for disease involvement, drug interactions, or functional mechanism, and it does not serve as a biomarker or pose safety concerns. Its annotation signals only the existence of antisense transcription, which in other systems (e.g., viruses[1][3]) can regulate gene expression or participate in epigenetic silencing, but no such role is established for this locus in humans.

Other names

ENSG00000295391novel transcript, antisense to HSPH1

None known. No mechanisms of action for this transcript as a drug target.